Search

Your search keyword '"Carrasquillo, Minerva M"' showing total 641 results

Search Constraints

Start Over You searched for: Author "Carrasquillo, Minerva M" Remove constraint Author: "Carrasquillo, Minerva M"
641 results on '"Carrasquillo, Minerva M"'

Search Results

1. Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer's disease

2. Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction

3. Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy

4. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins

5. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

6. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

7. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases

8. Large- Scale Deep Proteomic Analysis in Alzheimer's Disease Brain Regions Across Race and Ethnicity

10. Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

11. Latent trait modeling of tau neuropathology in progressive supranuclear palsy

12. ABCA7 frameshift deletion associated with Alzheimer disease in African Americans

13. Assessment of the genetic variance of late-onset Alzheimer's disease

14. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease

16. Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease

17. Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort

18. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease

19. Plasma biomarkers of Alzheimer’s disease in a biracial, community‐based sample

20. Gliovascular molecular alterations in Alzheimer’s disease: a cross‐tissue, cross‐species study

21. Blood co‐expression network analysis identifies molecular pathways involved in cognitive resilience

23. Network‐based pipeline guides knowledge‐driven prioritization and validation of therapeutic target discovery for Alzheimer’s disease

24. Identification of genes and blood co‐expression networks associated with cerebrovascular neuroimaging phenotypes

25. Targeted plasma eQTL and pQTL to identify potential novel biomarkers for Alzheimer’s Disease in African Americans

26. DNA methylation clustered by predicted chromatin state reveals distinct association patterns with neuropathologic and biochemical measures in the AD brain

27. Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions

28. Novel late-onset Alzheimer disease loci variants associate with brain gene expression.

29. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

30. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry

31. Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort

32. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifiesLRRC4C, LHX5-AS1and nominates ancestry-specific lociPTPRK,GRB14, andKIAA0825as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium

33. Transethnic genome-wide scan identifies novel Alzheimer's disease loci

34. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression

36. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy

40. Apolipoprotein E

42. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy

43. Evaluating pathogenic dementia variants in posterior cortical atrophy

44. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting

46. Late-onset Alzheimer’s risk variants in memory decline, incident mild cognitive impairment, and Alzheimer’s disease

47. Single Cell Approaches Reveal Perturbed Brain Vascular Molecules in Alzheimer’s Disease

48. Integrative single‐nucleus RNAseq analysis identifies cell‐type‐specific expression perturbations in progressive supranuclear palsy

50. Association of DNA methylation from the temporal cortex and cerebellum with AD‐related neuropathology and biochemistry

Catalog

Books, media, physical & digital resources